As of 2024-12-14, the Fair Value of Vincerx Pharma Inc (VINC) is -4.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.19 USD, the upside of Vincerx Pharma Inc is -2,276.82%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.12 | -16.62 | -39.31 | -65.37 | -40.16 | -40.36 |
| YoY growth | -% | -13,750.00% | -136.52% | -66.29% | 38.57% | -3,478.56% |
| Market Cap (mil) | 6.21 |
| P/E | |
| Forward P/E |
| EPS | -0.81 |
| Avg earnings growth rate | -3,478.56% |
| TTM earnings | -27.03 |